{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:14:15Z","timestamp":1785338055538,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with systemic lupus erythematosus are more likely to receive THA than the general population. However, it is controversial whether SLE increases the risk of complications from THA. The purpose of this retrospective study was to reassess the risks from THA in patients with SLE under the management model of enhanced recovery after surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with systemic lupus erythematosus diagnosed from December 2011 to December 2017 and treated with THA were compared with THA patients with osteoarthritis. The data were extracted from the medical record system of our department. The chi-square test and t-test were used for comparison.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The postoperative blood loss in patients with SLE was significantly higher than that in the control group, and the postoperative hemoglobin (Hb) and hematocrit (Hct) in the control group were lower than those in the control group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). There was no significant difference in the rate of blood transfusion (9.733 vs 8.133 <jats:italic>P<\/jats:italic>\u2009=\u20090.3148) or other complications between the two groups (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Well-controlled and well-managed SLE will not increase the risk of complications in THA, but can increase the amount of perioperative blood loss. Therefore, perioperative blood management is still essential in SLE patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-021-04316-3","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T12:03:02Z","timestamp":1621425782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Does systemic lupus erythematosus increase the risk of complications from total hip arthroplasty?"],"prefix":"10.1186","volume":"22","author":[{"given":"Yongrui","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong Ke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"4316_CR1","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1001\/jama.1960.03030080028005","volume":"174","author":"EL Dubois","year":"1960","unstructured":"Dubois EL, Cozen L. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. Jama. 1960;174:966\u201371.","journal-title":"Jama"},{"issue":"5","key":"4316_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3899\/jrheum.130617","volume":"41","author":"C Mertelsmann-Voss","year":"2014","unstructured":"Mertelsmann-Voss C, Lyman S, Pan TJ, Goodman S, Figgie MP, Mandl LA. Arthroplasty rates are increased among US patients with systemic lupus erythematosus: 1991-2005. J Rheumatol. 2014;41(5):867\u201374.","journal-title":"J Rheumatol"},{"issue":"10","key":"4316_CR3","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3899\/jrheum.170837","volume":"45","author":"S Hussein","year":"2018","unstructured":"Hussein S, Suitner M, B\u00e9land-Bonenfant S, Baril-Dionne A, Vandermeer B, Santesso N, et al. Monitoring of osteonecrosis in systemic lupus Erythematosus: a systematic review and Metaanalysis. J Rheumatol. 2018;45(10):1462\u201376.","journal-title":"J Rheumatol"},{"issue":"1","key":"4316_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0883-5403(92)90032-L","volume":"7","author":"MH Huo","year":"1992","unstructured":"Huo MH, Salvati EA, Browne MG, Pellicci PM, Sculco TP, Johanson NA. Primary total hip arthroplasty in systemic lupus erythematosus. J Arthroplast. 1992;7(1):51\u20136.","journal-title":"J Arthroplast"},{"issue":"7","key":"4316_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1177\/0961203316676384","volume":"26","author":"SM Tse","year":"2017","unstructured":"Tse SM, Mok CC. Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus. Lupus. 2017;26(7):715\u201322.","journal-title":"Lupus"},{"key":"4316_CR6","doi-asserted-by":"publisher","first-page":"475489","DOI":"10.1155\/2015\/475489","volume":"2015","author":"JW Kennedy","year":"2015","unstructured":"Kennedy JW, Khan W. Total hip Arthroplasty in systemic lupus Erythematosus: a systematic review. Int J Rheumatol. 2015;2015:475489.","journal-title":"Int J Rheumatol"},{"issue":"7","key":"4316_CR7","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00264-018-3871-5","volume":"42","author":"DQ Chen","year":"2018","unstructured":"Chen DQ, Cancienne JM, Werner BC, Cui Q. Is osteonecrosis due to systemic lupus erythematosus associated with increased risk of complications following total hip arthroplasty? Int Orthop. 2018;42(7):1485\u201390.","journal-title":"Int Orthop"},{"issue":"8","key":"4316_CR8","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3899\/jrheum.151373","volume":"43","author":"JE Roberts","year":"2016","unstructured":"Roberts JE, Mandl LA, Su EP, Mayman DJ, Figgie MP, Fein AW, et al. Patients with systemic lupus erythematosus have increased risk of short-term adverse events after Total hip arthroplasty. J Rheumatol. 2016;43(8):1498\u2013502.","journal-title":"J Rheumatol"},{"issue":"9","key":"4316_CR9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1177\/0961203314566635","volume":"24","author":"UH Shah","year":"2015","unstructured":"Shah UH, Mandl LA, Mertelsmann-Voss C, Lee YY, Alexiades MM, Figgie MP, et al. Systemic lupus erythematosus is not a risk factor for poor outcomes after total hip and total knee arthroplasty. Lupus. 2015;24(9):900\u20138.","journal-title":"Lupus"},{"key":"4316_CR10","first-page":"183","volume":"38","author":"JJ Gholson","year":"2018","unstructured":"Gholson JJ, Wilkinson BG, Brown TS, Gao Y, Dowdle SB, Callaghan JJ. Systemic lupus Erythematosus is a risk factor for complications in Total joint Arthroplasty. Iowa Orthopaedic J. 2018;38:183\u201390.","journal-title":"Iowa Orthopaedic J"},{"key":"4316_CR11","doi-asserted-by":"crossref","unstructured":"Gu J, Zhang S, Chen L, Feng X, Li H, Feng H, et al. Performing a safe and effective Total hip Arthroplasty on patients with inactive or stably active systemic lupus Erythematosus with osteonecrosis. J Am Acad Orthopaedic Surg. 2020.","DOI":"10.5435\/JAAOS-D-20-00464"},{"issue":"1","key":"4316_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13075-020-02300-1","volume":"22","author":"CH Chen","year":"2020","unstructured":"Chen CH, Chen TH, Lin YS, Chen DW, Sun CC, Kuo LT, et al. The impact of systemic lupus erythematosus on the risk of infection after total hip arthroplasty: a nationwide population-based matched cohort study. Arthritis Res Ther. 2020;22(1):214.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"4316_CR13","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/j.arth.2013.12.028","volume":"29","author":"MS Woo","year":"2014","unstructured":"Woo MS, Kang JS, Moon KH. Outcome of total hip arthroplasty for avascular necrosis of the femoral head in systemic lupus erythematosus. J Arthroplast. 2014;29(12):2267\u201370.","journal-title":"J Arthroplast"},{"issue":"10","key":"4316_CR14","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1016\/j.arth.2016.03.023","volume":"31","author":"EA Schnaser","year":"2016","unstructured":"Schnaser EA, Browne JA, Padgett DE, Figgie MP, D'Apuzzo MR. Perioperative complications in patients with inflammatory Arthropathy undergoing Total hip Arthroplasty. J Arthroplast. 2016;31(10):2286\u201390.","journal-title":"J Arthroplast"},{"issue":"8","key":"4316_CR15","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/art.1780250809","volume":"25","author":"CA Dorsch","year":"1982","unstructured":"Dorsch CA, Meyerhoff J. Mechanisms of abnormal platelet aggregation in systemic lupus erythematosus. Arthritis Rheum. 1982;25(8):966\u201373.","journal-title":"Arthritis Rheum"},{"key":"4316_CR16","unstructured":"Shevchuk SV. State of adhesive-aggregative function of platelets in patients with systemic lupus erythematosus. Lik Sprava. 2007;(1\u20132):27\u201332."},{"issue":"4","key":"4316_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrrheum.2018.38","volume":"14","author":"P Linge","year":"2018","unstructured":"Linge P, Fortin PR, Lood C, Bengtsson AA, Boilard E. The non-haemostatic role of platelets in systemic lupus erythematosus. Nat Rev Rheumatol. 2018;14(4):195\u2013213.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"4316_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ajh.1128","volume":"67","author":"H Takahashi","year":"2001","unstructured":"Takahashi H, Moroi M. Antibody against platelet membrane glycoprotein VI in a patient with systemic lupus erythematosus. Am J Hematol. 2001;67(4):262\u20137.","journal-title":"Am J Hematol"},{"issue":"11","key":"4316_CR19","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1016\/j.arth.2017.06.021","volume":"32","author":"J Merayo-Chalico","year":"2017","unstructured":"Merayo-Chalico J, G\u00f3nzalez-Contreras M, Ort\u00edz-Hern\u00e1ndez R, Alcocer-Varela J, Marcial D, G\u00f3mez-Mart\u00edn D. Total hip Arthroplasty outcomes: an 18-year experience in a single center: is systemic lupus Erythematosus a potential risk factor for adverse outcomes? J Arthroplast. 2017;32(11):3462\u20137.","journal-title":"J Arthroplast"},{"issue":"1","key":"4316_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11999-013-3134-0","volume":"472","author":"DR Whiting","year":"2014","unstructured":"Whiting DR, Gillette BP, Duncan C, Smith H, Pagnano MW, Sierra RJ. Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities. Clin Orthop Relat Res. 2014;472(1):66\u201372.","journal-title":"Clin Orthop Relat Res"},{"issue":"12","key":"4316_CR21","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.arth.2015.05.050","volume":"30","author":"DR Whiting","year":"2015","unstructured":"Whiting DR, Duncan CM, Sierra RJ, Smith HM. Tranexamic acid benefits Total joint Arthroplasty patients regardless of preoperative hemoglobin value. J Arthroplast. 2015;30(12):2098\u2013101.","journal-title":"J Arthroplast"},{"issue":"1","key":"4316_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12891-019-2767-x","volume":"20","author":"ZY Huang","year":"2019","unstructured":"Huang ZY, Huang Q, Zeng HJ, Ma J, Shen B, Zhou ZK, et al. Tranexamic acid may benefit patients undergoing total hip\/knee arthroplasty because of haemophilia. BMC Musculoskelet Disord. 2019;20(1):402.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"4316_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tmrv.2019.10.001","volume":"34","author":"BL Houston","year":"2020","unstructured":"Houston BL, Uminski K, Mutter T, Rimmer E, Houston DS, Menard CE, et al. Efficacy and safety of tranexamic acid in major non-cardiac surgeries at high risk for transfusion: a systematic review and meta-analysis. Transfus Med Rev. 2020;34(1):51\u201362.","journal-title":"Transfus Med Rev"},{"issue":"5","key":"4316_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/00002281-200309000-00002","volume":"15","author":"I Kang","year":"2003","unstructured":"Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol. 2003;15(5):528\u201334.","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"4316_CR25","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1177\/0961203319862609","volume":"28","author":"Z Li","year":"2019","unstructured":"Li Z, Du Y, Xiang S, Feng B, Bian Y, Qian W, et al. Risk factors of perioperative complications and transfusion following total hip arthroplasty in systemic lupus erythematosus patients. Lupus. 2019;28(9):1134\u201340.","journal-title":"Lupus"},{"issue":"1","key":"4316_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00590-012-0939-6","volume":"23","author":"Y Kang","year":"2013","unstructured":"Kang Y, Zhang ZJ, Zhao XY, Zhang ZQ, Sheng PY, Liao WM. Total hip arthroplasty for vascular necrosis of the femoral head in patients with systemic lupus erythematosus: a midterm follow-up study of 28 hips in 24 patients. Eur J Orthop Surg Traumatol. 2013;23(1):73\u20139.","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"6","key":"4316_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2106\/00004623-198769060-00003","volume":"69","author":"AD Hanssen","year":"1987","unstructured":"Hanssen AD, Cabanela ME, Michet CJ Jr. Hip arthroplasty in patients with systemic lupus erythematosus. J Bone Joint Surg Am. 1987;69(6):807\u201314.","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"4316_CR28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/1534734615604776","volume":"14","author":"S Akita","year":"2015","unstructured":"Akita S. Lower extremity wounds in patients with idiopathic thrombocytopenic Purpura and systemic lupus Erythematosus. Int J Low Extrem Wounds. 2015;14(3):224\u201330.","journal-title":"Int J Low Extrem Wounds"},{"issue":"1","key":"4316_CR29","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s13018-020-02051-4","volume":"15","author":"Z He","year":"2020","unstructured":"He Z, Zhou K, Tang K, Quan Z, Liu S, Su B. Perioperative hypoalbuminemia is a risk factor for wound complications following posterior lumbar interbody fusion. J Orthop Surg Res. 2020;15(1):538.","journal-title":"J Orthop Surg Res"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04316-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04316-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04316-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T12:03:15Z","timestamp":1621425795000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04316-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4316"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04316-3","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"22 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board of West China Hospital approved this retrospective study. All the methods of this study were performed in accordance with the relevant rules.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"457"}}